Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
WPMDE2
- Development stage
- Unknown
- Lead developer
- EXOSOMM
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Oral
01
Overview
WPMDE2 (Whey Protein Milk-Derived Exosomes 2) is an orally administered nutritional supplement composed of bovine milk-derived extracellular vesicles (exosomes). Developed by Exosomm Ltd., it is being investigated as a naturally derived adjunct therapy for the treatment of mild to severe ulcerative colitis (UC). The supplement leverages the bioactive properties of milk-derived exosomes to potentially modulate inflammatory pathways, improve clinical disease activity, and support mucosal healing. It is currently undergoing evaluation in Phase 1 clinical trials to establish its safety, tolerability, and efficacy in reducing inflammatory markers such as fecal calprotectin in UC patients.
- Other names
- Whey Protein Milk-Derived ExosomesWPMDE2WPMDE-2WPMDE 2Whey Protein Milk-Derived Exosomes 2
Beyond the preview
Go deeper on WPMDE2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on WPMDE2.